Ferrimed
Iron Polymaltose Syrup 100ml
Ferrimed Iron Polymaltose Syrup 100ml is a sugar-free syrup that can be taken daily to give the body its necessary iron needs. Iron is known to help metabolise proteins and plays a part in the production of haemoglobin and red blood cells. It’s also renowned for reducing fatigue, treating insomnia and improving the immune system to help fight infections.
Out of Stock
Pharmacy collection
This product is available for collection at a Clicks pharmacy only.
Dispensed by pharmacist
Dispensed at the professional discretion of a Clicks Pharmicist
Find in-store
See if we have this item in your closest store
More Information
Detailed information
Description:
Ferimed Iron Polymaltose Syrup 100 ml
Detailed Description:
Ferrimed® capsules.
Ferrimed® D.S. chewable tablets.
Ferrimed® syrup.
Scheduling status:
S0.
Proprietary name (and dosage form):
Composition:
Ferrimed® Capsules:
Each capsule contains 50 mg elemental iron as an iron (III)-hydroxide polymaltose complex and 150 µg folic acid.
Sugar-free.
Ferrimed® D.S. chewable tablets:
Each tablet contains 100 mg elemental iron as an iron (III)-hydroxide polymaltose complex.
Sugar-free.
Ferrimed® syrup:
Each 5 ml contains 50 mg elemental iron as an iron (III)-hydroxide polymaltose complex.
Preservatives:
Methylhydroxybenzoate - 0.0583% m/v.
Propylhydroxybenzoate - 0.0167% m/v.
Contains sugar.
Pharmacological classification.
A 8.3 erythropoietics (haematinics).
Pharmacological action:
Iron is an essential constituent of the body and is necessary for haemoglobin formation and for the oxidative processes of living tissue.
Pharmacodynamic properties:
Ferrimed® contains iron polymaltose consisting of a polynuclear iron (III)-hydroxide core, which is surrounded by a number of non-covalently bound polymaltose molecules.
The absorbed iron is stored mainly in the liver, where it is bound to ferritin. Later in the bone marrow it is incorporated into haemoglobin.
Pharmacokinetic-properties:
Absorption occurs principally in the duodenum and proximal jejunum.
Indications:
Iron (III)-hydroxide polymaltose complex in the Ferrimed® range is indicated for the treatment of iron deficiency and iron deficiency anaemia.
Contra-indications:
Cases of iron overload (haemochromatosis; haemosiderosis; chronic haemolysis or lead induced anaemia).
Disturbances in iron utilisation (thalassaemia or sideroblastic anaemia).
Patients showing hypersensitivity and intolerance to iron. Patients receiving repeated blood transfusions.
All forms of anaemia without iron deficiency, e.g. megaloblastic anaemia stemming from Vitamin B12 deficiency and pernicious anaemia.
In cases of inflammatory conditions or malignancy, iron is deposited in the reticulo-endothelial system and iron mobilisation and utilisation do not occur until the underlying disease is treated.
Identification:
Ferrimed® capsules: The capsule has an opaque blue cap, with an opaque brown body and contains a milk chocolate-coloured, fine powder speckled with deeper brown granules.
Ferrimed® D.S. chewable tablets: brown and white speckled tablet.
Ferrimed® syrup: a clear, brown, viscous solution, with a creamy vanilla odour.
Presentation:
Ferrimed® capsules: securitainer containing 60 or 120 capsules.
Ferrimed® D.S. chewable tablets: carton containing 30 or 90 tablets in blister packs.
Ferrimed® syrup: 100 ml amber glass bottle with a dropper (marked in millilitres) and a medicinal spoon.
Holder of the registration certificate Nycomed (Pty) Ltd.
Each 5 ml contains:
50 mg elemental iron as iron (III) - hydroxide polymaltose complex.
Sugar 1.0 g/5ml.
Nycomed.
Pack size:
100 ml
Quantity in pack:
1
Marketing description:
Ferrimed® syrup.
Iron polymaltose.
Swissiron.
100 ml syrup.
Brand:
Ferrimed
Package type:
Box
How to use
Usage instructions:
Dosage and directions for use:
Ferrimed® capsules:
Therapeutic dose: Two to four capsules (100 mg to 200 mg elemental iron, and 300 µg to 600 µg folic acid) per day or as recommended by a medical practitioner.
Supplementary dose: One to two capsules (50 mg to 100 mg elemental iron, and 150 µg to 300 µg folic acid) per day.
The capsules must be taken in divided doses with meals.
Ferrimed® D.S. Chewable Tablets:
Therapeutic dose: Chew or swallow one to two tablets (100 mg to 200 mg elemental iron) per day.
The tablets must be taken in divided doses with meals.
Ferrimed® Syrup: Dosage Regimen:
Adults - Initially 25 mg to 50 mg elemental iron (2.5 ml to 5 ml syrup) per day increased with 25 to 50 mg (2.5 to 5 ml) increments to 200 mg (20 ml syrup) per day. The syrup should be taken in two to three divided doses per day, with meals.
Children (6 - 12 years) - 25 mg to 125 mg elemental iron (2.5 ml to 12.5 ml syrup) (3 mg elemental iron/kg body weight) per day. The syrup should be taken in one or two divided doses per day, with meals.
Children (2 - 5 years) - 15 mg to 50 mg elemental iron (1.5 ml to 5 ml syrup) (3 mg elemental iron/kg body weight) per day. The syrup should be taken in one or two divided doses per day, with meals.
Infants (6 months - 2 years) - Up to 6 mg elemental iron/kg body weight per day. The syrup should be taken in 3 to 4 divided doses with feeds.
Infants (under 6 months) - 10 to 25 mg elemental iron (1 ml to 2.5 ml syrup) per day. The syrup should be taken in 3 to 4 divided doses with feeds. The dose must take into account any supplemental iron contained in the formulation.
Low birth weight infants or infants with low iron stores - Initially 2 mg/kg body weight per day, decreased gradually to 1 mg/kg body weight per day.
See enclosed package insert.
Shake bottle before use.
Storage instructions:
Store below 25 degrees C in a dark, dry place.
Warnings:
Side-effects and special precautions:
The oral administration of iron preparations may cause gastro-intestinal irritation and abdominal pain with nausea and vomiting. Other gastro-intestinal effects may include either diarrhoea or constipation. The faeces may be coloured black. Lassitude and headache may occur.
Notice to diabetics:
Ferrimed® Capsules = 0.1 bread units per capsule.
Ferrimed® D.S. Chewable Tablets = 0.04 bread units per tablet.
Ferrimed® Syrup = 0.2 bread units per 5 ml syrup.
Known symptoms of overdosage and particulars of its treatment.
See side-effects and special precautions.
Acute iron overdose can be divided into four stages.
In the first phase of acute iron overdosage, which occurs up to 6 hours after oral ingestion, gastro-intestinal toxicity, notably vomiting and diarrhoea, predominates. Other effects may include cardiovascular disorders such as hypotension and tachycardia; metabolic changes including acidosis and hyperglycaemia; as well as central nervous system depression ranging from lethargy to coma. Patients with mild to moderate poisoning only do not generally progress past this first phase.
The second phase may occur at 6 to 24 hours after ingestion and is characterised by a temporary remission or clinical stabilisation. In the third phase gastro-intestinal toxicity recurs together with shock, metabolic acidosis, convulsions, coma, hepatic necrosis and jaundice, hypoglycaemia, coagulation disorders, oliguria or renal failure and pulmonary oedema.
The fourth phase may occur several weeks after ingestion and is characterised by gastro-intestinal obstruction and possibly late hepatic damage.
In treating acute iron poisoning, speed is essential to block absorption of iron from the alimentary tract. Emesis or lavage should be considered and serum-iron concentrations may be an aid to estimating the severity of the poisoning. Chelation therapy with desferrioxamine, according to the instructions on the package insert, may be necessary.
Treatment is symptomatic and supportive.
Keep out of reach of children.